Navigation Links
Nation's Laboratory Response Network Marks First Decade of Protecting Public Health
Date:3/30/2009

SILVER SPRING, Md., March 30 /PRNewswire-USNewswire/ -- The Laboratory Response Network (LRN), the national laboratory system charged with protecting the public in health emergencies, will mark its first decade at its national meeting in Orlando, Florida, April 1-3, 2009.

Founded in 1999 by the Association of Public Health Laboratories (APHL), the Centers for Disease Control and Prevention (CDC) and the Federal Bureau of Investigation (FBI) to test for agents of bioterrorism, the Laboratory Response Network has evolved to become the nation's laboratory resource for response to emerging infectious diseases, toxic spills, natural disasters, chemical terrorism and other public health threats.

LRN member laboratories conduct confirmatory testing of specimens referred by clinical laboratories, law enforcement agencies, the armed forces and other partner agencies. The results of their analysis determine emergency response measures.

The first trial of the LRN came in 2001. "Two weeks after the state of Florida finished training its laboratorians in emergency response measures, a Florida LRN reference lab identified Bacillus anthracis, the index case for the anthrax events of 2001, in a clinical specimen," remembers APHL Executive Director Scott Becker. "That day the concept of a national, rapid response laboratory network proved its worth."

In subsequent years, the LRN's portfolio expanded in response to outbreaks of SARS, monkey pox and avian influenza. Its productivity level was high. In one twelve-month period during 2006, over 5,000 tests for unknown substances were performed by state public health laboratories. A diverse membership of state and local public health labs, veterinary, agricultural, military labs, water and food testing laboratories tackled the workload using standardized methods and tests to assure accuracy and consistency across the network.

In 2003, the LRN added a chemical component, the Laboratory Response Network for Chemical Terrorism Preparedness, or LRN-C. Sixty-two state, territorial and metropolitan public health laboratories at three levels of capability now participate in the LRN-C.

Development of a radiological component of the LRN awaits availability of funding. Currently the CDC is pursuing newer and more rapid methods to analyze clinical specimens for radioactive materials.

"The gap in radiological capability is a serious concern," stated APHL President Frances Downes, DrPH, director of the Michigan Public Health Laboratory. "As a laboratory first responder, the LRN must position itself strategically to respond to emerging threats, whether they be the next SARS or chemical terrorism or a dirty bomb. We can't assume that the threats of the next ten years will all be biological."

The Association of Public Health Laboratories is a national non-profit located in Silver Spring, MD, that is dedicated to working with members to strengthen governmental laboratories with a public health mandate. By promoting effective programs and public policy, APHL strives to provide public health laboratories with the resources and infrastructure needed to protect the health of US residents and to prevent and control disease globally.


'/>"/>
SOURCE Association of Public Health Laboratories
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Kiadis Pharma Receives Two Orphan Drug Designations for Reviroc(TM) From the FDA
2. The COSHAR Foundation Urges Parents to Ensure Children Are Up-to-Date on Vaccinations
3. Parents Make Donations to National Autism Association for Cutting-Edge Research
4. Celator(R) Pharmaceuticals Successfully Uses Nanoparticles to Administer Hydrophobic Drug Combinations
5. Halozyme Therapeutics Presents Findings on Combinations of rHuPH20 Enzyme With Bisphosphonates at the American Association for Cancer Research Conference
6. Flu Season Is Here -- Vaccinations Are Still Plentiful
7. CVS/pharmacy Offers Flu Vaccinations in Over 4,000 Stores
8. Sports Legacy Institute Announces Findings of Forensic Examinations on Wrestler Chris Benoits Brain
9. BARC Central Laboratory Joins Alzheimers Association Research Roundtable
10. Quest Diagnostics ClariSure(TM) Postnatal Molecular Test Receives Clinical Laboratory Approval from New York State
11. deCODE Receives California Clinical Laboratory License
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... , April 20, 2017  RXi Pharmaceuticals ... innovative therapeutics that address significant unmet medical needs, ... from the Company,s consumer product development program, based ... the Society for Investigative Dermatology (SID) 76 th ... advance and promote the sciences relevant to skin ...
(Date:4/20/2017)... BOSTON , April 20, 2017   ZappRx, Inc ... the specialty drug prescribing process, today announced it closed $25 ... Fund, a venture capital firm based in Seattle ... Qiming Venture Partners . The Series B round included ... A round in 2014, and GV (formerly Google ...
(Date:4/20/2017)... 20, 2017 Eyevensys, a private ... non-viral gene expression technology that enables the safe, local, ... address a wide range of ophthalmic diseases, announces it ... products Regulatory Agency (MHRA) to advance its technology into ... ...
Breaking Medicine Technology:
(Date:4/28/2017)... , ... April 28, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House ... name the Creator responds to and which He does not. Yisrayl says with so ... one is the true name, but he says with a little Scripture, backed with a ...
(Date:4/28/2017)... ... April 28, 2017 , ... Phytomer USA ... region. Côté has 20+ years of experience within the beauty industry, ranging from ... an array of high-end cosmetic brands, retail brands and outlets in Canada and ...
(Date:4/28/2017)... ... April 28, 2017 , ... Woolsy Corporation ... supplements, through its Nova Skin Sciences division, recently announced the launch of Allumière ... with the power of an anti-aging concentrate. , Anogeissus Leiocarpa Bark ...
(Date:4/28/2017)... ... ... Rob Lowe is a popular actor that has been in many different movies ... as the host of the “Informed” series. The program focuses on many important issues ... focuses on thyroid cancer. , Although thyroid cancer is an uncommon type of cancer, ...
(Date:4/28/2017)... ... April 28, 2017 , ... Christie Medical Holdings, Inc. ... alliance with B. Braun Medical Inc. , a leader in infusion therapy and ... with as many as 90 percent of hospital patients receiving a peripheral IV catheter ...
Breaking Medicine News(10 mins):